Summary:
- The article provides an overview of ibogaine, a naturally occurring psychoactive alkaloid derived from the root bark of the *Tabernanthe iboga* shrub, primarily found in Central Africa.
- It discusses the substance's pharmacological potential in treating opioid and substance use disorders, noting its ability to potentially reduce withdrawal symptoms and cravings.
- The text highlights significant medical concerns, including the lack of FDA approval, the current legal status of the drug, and the serious cardiovascular risks (such as arrhythmias) associated with its consumption.